04.06.2019 Issue 166

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

 Director, Real World Value
and Evidence, Oncology

In this position, the Director, Real-World Value and Evidence, Oncology will be responsible for leading market access scientific strategy, evidence generation, and dissemination plans for assigned therapeutic areas, products or indications, within Janssen Oncology.

US Market Access Engagement Manager/ Director

Senior Medical Writer

Senior Research Analyst (HEOR)

Medical Statistician

Senior Health Economics & Real-World Evidence (HE-RWE) Scientist

Senior Health Economics/Outcomes Researcher

Senior Health Economist (HTA and Market Access)

Head of Economic Modelling


Xarelto Ad with List Price Airs

Speakers Talk Drug Coupons at AMCP

IQVIA’s Long Talks Health Care Trends

AMCP 2019 Session Spotlights Disruptors, Innovators

Industry Spotlight


Conferences Webinars
Decision Analytic Modelling for Economic Evaluation
    April 8-9, York, England

Copay Accumulator Programs Summit West
    April 9, San Francisco, California

Formulary, Co-Pay and Access Summit
    April 9-11, San Francisco, California

Comparative Effectiveness Research: Recent Applications and Future Investments
    April 9, Washington, D.C.

Big Data, RWD and RWE: What’s the Difference and How is it Changing the Research Landscape?
    April 15

New Drug Pricing Strategies for a Changing Global Market
    April 24

Beyond Drug Development: The Increasing Role of Real-World Data and Real-World Evidence in Medical Research
    April 25


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)


Special Thanks to Our Partners:
                   Truven         
              Evidera    HealthCore    University of FL
      Xcenda    OM1    Parexel    Jefferson    Dymaxium    
      Precision Xtract    Pharmerit    eMax Health    Sciformix
       Evidence Partners     ICON